熱門資訊> 正文
Sutro Biopharma falls as it announces 1-for-10 reverse stock split
2025-12-01 21:16
- Sutro Biopharma (STRO) said on Monday that its board has approved a reverse stock split of the company's outstanding shares of common stock at a ratio of 1-for-10.
- Sutro’s common stock will begin trading on a post-reverse stock split basis on December 3, 2025, under the company's existing trading symbol “STRO.”
- The reverse stock split is intended to regain compliance with Nasdaq’s minimum bid price requirement of $1.00 per share.
- The reverse stock split reduces the number of shares of the company's outstanding common stock from approximately 85.19M shares to approximately 8.52M.
- Sutro Biopharma (STRO) shares were down more than 12% in premarket trading.
More on Sutro Biopharma
- Sutro Biopharma, Inc. (STRO) Discusses Strategic Reset and Progress in Next-Generation ADC Pipeline and Platform Innovation - Slideshow
- Sutro Biopharma, Inc. (STRO) Discusses Strategic Reset and Progress in Next-Generation ADC Pipeline and Platform Innovation Transcript
- Sutro Biopharma announces restructuring to extend cash runway
- Seeking Alpha’s Quant Rating on Sutro Biopharma
- Historical earnings data for Sutro Biopharma
推薦文章
美股機會日報 | 美國1月「小非農」不及預期！禮來績后一度大漲10%，財報強勁超預期
華盛早報 | 闢謠！税收傳聞不實；「AI搶飯碗」引拋售潮！納指跌近1.5%；黃金、白銀暴力反彈，華爾街堅定看多
全面甩賣軟件股！美股爆發AI恐慌，Anthropic掀起SaaS拋售潮
財報速遞 | 超微電腦盤后一度漲逾10%！強勁業績展望預示AI需求增長
美股機會日報 | 貴金屬「大逆轉」！金銀價再度大漲，機構建議市場回穩再進場；閃迪盤前續漲4%，年內已累漲180%
金銀暴跌后「暴力」反彈！華爾街堅定看多：邏輯未破，黃金牛市仍未結束（附相關標的）
搶跑1.5萬億美元造富神話！如何在IPO前投資SpaceX？最全攻略來了
新股申購 | 「全球鋰電設備龍頭」先導智能今起招股！引入歐萬達基金等基石投資者
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
